PGR and leiomyoma: A selective progesterone receptor modulator (SPRM), ulipristal acetate (UPA), was registered as a drug in preoperative management of symptomatic myomas in order to reduce the size of tumors and eliminate abnormal uterine bleeding associated with fibroids [5,6,7].